Kura Oncology Inc’s recent filing unveils that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $57916.0 on May 20 ’24. In the deal valued at $22.15 per share,2,615 shares were sold. As a result of this transaction, Bair Teresa Brophy now holds 68,979 shares worth roughly $1.28 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DOYLE THOMAS JAMES sold 2,318 shares, generating $41,262 in total proceeds. Upon selling the shares at $17.80, the SVP, Finance & Accounting now owns 48,093 shares.
Before that, Bair Teresa Brophy sold 2,053 shares. Kura Oncology Inc shares valued at $36,544 were divested by the Chief Legal Officer at a price of $17.80 per share. As a result of the transaction, Bair Teresa Brophy now holds 68,979 shares, worth roughly $1.28 million.
UBS initiated its Kura Oncology Inc [KURA] rating to a Buy in a research note published on October 24, 2024; the price target was $27. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Mizuho began covering KURA with “Buy” recommendation on December 22, 2023. BofA Securities started covering the stock on August 11, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 5.75% to $18.57. Over the last five days, the stock has gained 5.99%. Kura Oncology Inc shares have risen nearly 29.14% since the year began. Nevertheless, the stocks have risen 117.96% over the past one year. While a 52-week high of $24.17 was reached on 03/11/24, a 52-week low of $8.17 was recorded on 01/23/24. SMA at 50 days reached $18.67, while 200 days put it at $20.16.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 17.80, which if violated will result in even more drops to 17.04. On the upside, there is a resistance level at 19.53. A further resistance level may holdings at 20.49. The Relative Strength Index (RSI) on the 14-day chart is 57.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 35.88%. Stochastics %K at 57.27% indicates the stock is a holding.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2024-10-31, growing by 0.61 million shares to a total of 10.8 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 10.19 million shares. There was a rise of 5.67%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 27, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $10.50 price target.
